Cargando…

Hormone replacement therapy and outcomes for women with non-small-cell lung cancer: can an association be confirmed?

BACKGROUND: A recent report suggested that women who had been taking hormone replacement therapy (hrt) experienced significantly decreased survival after a lung cancer diagnosis. Given the large cohort of women who have received hrt, it is important to try to confirm that association. METHODS: We re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayeni, O., Robinson, A.
Formato:	Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2009
Materias:	Medical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695714/ https://www.ncbi.nlm.nih.gov/pubmed/19526081

Ejemplares similares

Optimizing the management of advanced non-small-cell lung cancer: a personal view
por: Vincent, M.D.
Publicado: (2009)

Retrospective practice review of treatment of metastatic non-small-cell lung cancer with second-line erlotinib
por: Melosky, B., et al.
Publicado: (2008)

Safety of adjuvant endocrine therapies in hormone receptor–positive early breast cancer
por: Sehdev, S., et al.
Publicado: (2009)

An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor– positive early breast cancer
por: Verma, S., et al.
Publicado: (2009)

Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer
por: Hsu, Robert, et al.
Publicado: (2023)

Maintenance Therapies for Non-Small Cell Lung Cancer
por: Blais, Normand, et al.
Publicado: (2014)

The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer
por: Chun, Stephen G., et al.
Publicado: (2017)

Hormone replacement therapy and lung cancer risk in women: a meta-analysis of cohort studies: Hormone replacement therapy and lung cancer risk
por: Jin, Chao, et al.
Publicado: (2019)

Reproductive and Hormonal Factors in Relation to Lung Cancer Among Nepali Women
por: Vohra, Sanah N., et al.
Publicado: (2019)

Targeted therapy of RET fusion-positive non-small cell lung cancer
por: Shen, Zixiong, et al.
Publicado: (2022)

Local therapy treatment conditions for oligometastatic non-small cell lung cancer
por: Zhang, Suli, et al.
Publicado: (2022)

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer
por: Shen, Qinglin, et al.
Publicado: (2023)

Stage IV non-small cell lung cancer among young individuals: Incidence, presentations, and survival outcomes of conventional therapies
por: Cai, Jing-Sheng, et al.
Publicado: (2022)

The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastases
por: Billena, Cole, et al.
Publicado: (2023)

Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer
por: Hu, Yan, et al.
Publicado: (2021)

The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer
por: Saarenheimo, Jatta, et al.
Publicado: (2019)

CT Appearance Pattern After Stereotactic Body Radiation Therapy Predicts Outcomes in Early-Stage Non-Small-Cell Lung Cancer
por: Yang, Yan, et al.
Publicado: (2021)

Anthropomorphic Phantoms for Confirmation of Linear Accelerator-Based Small Animal Irradiation
por: Perks, Julian R, et al.
Publicado: (2015)

Skeletal muscle area predicts the outcomes of non-small-cell lung cancer after trimodality therapy
por: Watanabe, Kenji, et al.
Publicado: (2023)

Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy
por: Kumar, Sameera S., et al.
Publicado: (2017)

Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer
por: Marcus, David M., et al.
Publicado: (2013)

Effects of obesity and hormone therapy on surgically-confirmed fibroids in postmenopausal women
por: Sommer, Eva M., et al.
Publicado: (2015)

Pattern of Treatment Initiation and Outcomes for Patients With Metastatic Non-small Cell Lung Cancer in Ontario
por: Ding, Jerry W, et al.
Publicado: (2022)

Use of Pralsetinib as Neoadjuvant Therapy for Non-Small Cell Lung Cancer Patient With RET Rearrangement
por: Zhou, Ning, et al.
Publicado: (2022)

NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance
por: Liu, Fangfang, et al.
Publicado: (2022)

Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy
por: Xiang, Zhangqiang, et al.
Publicado: (2022)

Microwave ablation plus camrelizumab monotherapy or combination therapy in non-small cell lung cancer
por: Huang, Yahan, et al.
Publicado: (2022)

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer
por: Fang, Qiyu, et al.
Publicado: (2023)

Periodontal treatment outcomes in post menopausal women receiving hormone replacement therapy
por: Cekici, Ali, et al.
Publicado: (2015)

Hormone Replacement Therapy in Females Can Decrease the Risk of Lung Cancer: A Meta-Analysis
por: Yao, Yanwen, et al.
Publicado: (2013)

Histomorphological transformation from non-small cell lung carcinoma to small cell lung carcinoma after targeted therapy or immunotherapy: A report of two cases
por: Liu, Hao, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Small Academic Hospital Experience
por: Factor, Oren B., et al.
Publicado: (2014)

The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer
por: He, Tianyu, et al.
Publicado: (2022)

Clinical Characteristics and Treatment Outcomes of 65 Patients With BRAF-Mutated Non-small Cell Lung Cancer
por: Mu, Yuxin, et al.
Publicado: (2020)

Current and novel therapeutic strategies for optimizing immunotherapy outcomes in advanced non-small cell lung cancer
por: Martin, Claudio, et al.
Publicado: (2022)

Perioperative outcomes of robotic lobectomy for early-stage non-small cell lung cancer in elderly patients
por: Gallina, Filippo Tommaso, et al.
Publicado: (2022)

Epigenetic Therapy of Non-Small Cell Lung Cancer Using Decitabine (5-Aza-2′-Deoxycytidine)
por: Momparler, Richard L.
Publicado: (2013)

The Emerging Role of Targeted Therapy and Immunotherapy in the Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Wong, Annick
Publicado: (2017)

Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer
por: Wiest, Nathaniel, et al.
Publicado: (2021)

HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies
por: Yu, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ra08hpssckk47862kq3ftqgr9m